Bartholomaeus W N, Reed W D, Joske R A, Shilkin K B
Immunology. 1981 Jun;43(2):219-26.
Autoantibody to the hepatocyte membrane antigen, liver-specific lipoprotein (LSP) was induced in mice by immunization with LSP-containing protein preparations from human, rat, rabbit and mouse liver and also with purified allogeneic LSP. Each of the strains of mice used (C57B1, BALB/c, C3H) showed the capacity to produce high titre autoantibody to LSP. Autoantibody to LSP demonstrated by passive haemagglutination was absorbed by normal mouse hepatocytes but not by kidney or spleen cells and reacted with the cell membrane of normal mouse hepatocytes by immunofluorescence. The liver was examined histologically in all mice and where inflammation was found it was attributable to the Freund's complete adjuvant used in immunization rather than liver protein immunogen. The demonstration of high titre autoantibody to LSP in mice without associated hepatitis contrasts with chronic hepatitis in man and experimental chronic hepatitis in rabbits where autoantibodies to LSP have been implicated in the pathogenesis of the disease.
用来自人、大鼠、兔和小鼠肝脏的含肝细胞膜抗原(肝特异性脂蛋白,LSP)的蛋白质制剂以及纯化的同种异体LSP免疫小鼠,可诱导小鼠产生针对LSP的自身抗体。所用的每种小鼠品系(C57B1、BALB/c、C3H)均显示出产生高滴度LSP自身抗体的能力。通过被动血凝反应检测到的LSP自身抗体可被正常小鼠肝细胞吸收,但不能被肾细胞或脾细胞吸收,并且通过免疫荧光与正常小鼠肝细胞的细胞膜发生反应。对所有小鼠的肝脏进行了组织学检查,发现有炎症的情况归因于免疫中使用的弗氏完全佐剂,而非肝蛋白免疫原。在无相关肝炎的小鼠中检测到高滴度LSP自身抗体,这与人类慢性肝炎以及兔实验性慢性肝炎形成对比,在这些疾病中,LSP自身抗体与疾病的发病机制有关。